Organoid artificial intelligence
There are research groups working on the symbiosis between artificial intelligence and biology. Brain cells are cultivated in vitro to transform them into stem cells and from that sample be able to reproduce a part of the human brain, which would be complemented remotely by a connection with an organoid battery to the computer processor.
Artificial Intelligence applied to health
With the advent of Artificial Intelligence applied to health, there are those who seek to replace the brain of the doctor by a machine and ignore the human factor in the doctor-patient relationship
Internal Medicine and the progresses in Genetics, Epigenetic, Nanotechnology, Biotechnology, Computer science, Cognitive Sciences, Robotics, among other disciplines.
The ideas turn into medical innovations when with them there are achieved new procedures, services or products that turn out to be useful for the human being.
Albert Einsten (Germany, 1879-1955) was saying “If you look for different results, do not do always the same thing “.
The concept of development is joined to the idea of progress, but it is necessary that the development is with equity, opposite case treats itself about an inadequate development.
For Nikola Tesla (Croatia, 1856-1943), “The development of the man depends fundamentally on the invention. It is the most important product of his creative brain. His final aim is the complete domain(control) of the mind over the material world and the utilization of the forces of the nature in favour of the human needs”.
Disruption and innovation. In health day after day they appear startups to create disruptive solutions in response to concrete problems.
Machines can only learn what man teaches them
Ada Lovelace (Londrés 1815 – 1852)
Mathematical and a writer. Author of the first algorithm for a machine.
Artificial Intelligence applied to Medicine
The future of the disabled patients (robotic exoskeletons)
18th European Congress of Internal Medicine (Lisbon, from 29th to 31th August, 2019)
The theme of the congress is “Innovation in Health Care: New Opportunities for Internal Medicine”. www.efim.org/ecim2019
One capsule to replace Insulin injections in the experimental phase
DNA nanorobots for cancer therapy: an important experience in the University of Arizona in basic stage of experimentation with animals. It would be promising in humans.